Aims. Delays to diagnosis and management of soft tissue sarcomas are preventable but still occur. The introduction of a referral proforma to the Thames Valley Cancer Network in 2005 and National guidelines in 2006 aimed to decrease the incidence of partially and inadequately managed soft tissue sarcomas. This study aims to assess referrals for partially or inadequately managed soft tissue sarcomas and their subsequent management. Methods. A prospective analysis of all patients referred to the Oxford Sarcoma Service following inadvertent excision of a soft tissue sarcoma between January 2010 and August 2011 was carried out. Pre-operative investigation and subsequent secondary managements were recorded. Patients with a diagnosis of dermatofibrosarcoma protuberans were excluded. Results. 24 patients (17 male) with a mean age of 54.3 (6–96), representing 14.5% of all soft tissue sarcomas during this time period were followed up following incomplete or inadvertent excision. 66% were referred from secondary care, 54% had no pre-operative imaging, with the remainder having incomplete imaging. 79% of lesions were found in the extremities, with 12.5 % presenting with metastatic disease. 79% required further surgery, with 8% requiring amputation. The most common pathologies were leiomyosarcoma (29.1%), fibromyxoid sarcoma (12.5%), spindle cell sarcoma (12.5 %) and liposarcoma (8.3%). Conclusion. The consequences of incomplete initial management of soft tissue sarcomas are a cause of significant morbidity and demand on health care services. The introduction of referral guidelines has not prevented the partial management of these lesions

Lisfranc injuries account for 0.2% of all fractures and have been linked to poorer functional outcomes, in particular resulting in post-traumatic arthritis, midfoot collapse and chronic pain. This study assesses the longitudinal functional outcomes in patients with low and high energy Lisfranc injuries treated both operatively and non-operatively. Patients above 16 years with Lisfranc injuries from January 2008 and December 2017 were identified through the Victorian Orthopaedic Trauma Outcomes (VOTOR) registry. Follow-up performed at 6, 12 and 24 months through telephone interviews with response rate of 86.1%, 84.2% and 76.2% respectively. Longitudinal functional outcome data using Global Outcome Assessment, EQ-5D-5L, numerical pain scale, Short-Form 12, the WHO Disability Assessment Schedule and return to work status were collected. Univariate analysis was performed and variables showing a significant difference between groups (p < 0.25) were analysed with multivariable mixed effects regression model. 745 patients included in this retrospective cohort study. At 24 months, both the operative and non-operative groups demonstrated similar functional outcomes trending towards an improvement. Mixed effect regression models for the EQ items for mobility (OR 1.80, CI 0.91 – 3.57), self-care (OR 1.95, 95% CI 1.09-3.49), usual activities (OR 1.10, 95% CI 0.99-1.03), pain (OR 1.07, 95% CI 0.61-1.89), anxiety (OR 1.29, 95% CI 0.72-2.34) and pain scale (OR 1.07, 95% CI 0.51 – 2.22) and return to work (OR 1.28, 95% CI 0.56-2.91) between groups were very similar and not statistically significantly different. We concluded that there was no statistically significant difference between operative and non-operative patients with low and high energy Lisfranc injuries. Current clinical practices in Lisfranc injury management are appropriate and not inadvertently causing any further harm to patients. Future research comparing fracture patterns, fixation types and corresponding functional outcomes can help determine gold standard Lisfranc injury management

Timely and competent treatment of paediatric fractures is paramount to a healthy future working population. Anecdotal evidence suggests that children travel greater distances to obtain care compared to adults causing economic and geographic inequities. This study aims to qualify the informal regionalization of children's fracture care in Ontario. The results could inform future policy on resource distribution and planning of the provincial health care system. A retrospective cohort study was conducted examining two of the most common paediatric orthopaedic traumatic injuries, femoral shaft and supracondylar humerus fractures (SCH), in parallel over the last 10 years (2010-2020) using multiple linked administrative databases housed at the Institute for Clinical Evaluative Sciences (ICES) in Toronto, Ontario. We compared the distance travelled by these pediatric cohorts to clinically equivalent adult fracture patterns (distal radius fracture (DR) and femoral shaft fracture). Patient cohorts were identified based on treatment codes and distances were calculated from a centroid of patient home forward sortation area to hospital location. Demographics, hospital type, and closest hospital to patient were also recorded. For common upper extremity fracture care, 84% of children underwent surgery at specialized centers which required significant travel (44km). Conversely, 67% of adults were treated locally, travelling a mean of 23km. Similarly, two-thirds of adult femoral shaft fractures were treated locally (mean travel distance of 30km) while most children (84%) with femoral shaft fractures travelled an average of 63km to specialized centers. Children who live in rural areas travel on average 51km more than their adult rural-residing counterparts for all fracture care. Four institutions provide over 75% of the fracture care for children, whereas 22 institutions distribute the same case volume in adults.?. Adult fracture care naturally self-organizes with proportionate distribution without policy-directed systemization. There is an unplanned concentration of pediatric fracture care to specialized centers in Ontario placing undue burden on pediatric patients and inadvertently stresses the surgical resources in a small handful of hospitals. In contrast, adult fracture care naturally self-organizes with proportionate distribution without policy-directed systemization. Patient care equity and appropriate resource allocation cannot be achieved without appropriate systemization of pediatric fracture care

Aims. The risk to patients and healthcare workers of resuming elective orthopaedic surgery following the peak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been difficult to quantify. This has prompted governing bodies to adopt a cautious approach that may be impractical and financially unsustainable. The lack of evidence has made it impossible for surgeons to give patients an informed perspective of the consequences of elective surgery in the presence of SARS-CoV-2. This study aims to determine, for the UK population, the probability of a patient being admitted with an undetected SARS-CoV-2 infection and their resulting risk of death; taking into consideration the current disease prevalence, reverse transcription-polymerase chain reaction (RT-PCR) testing, and preassessment pathway. Methods. The probability of SARS-CoV-2 infection with a false negative test was calculated using a lower-end RT-PCR sensitivity of 71%, specificity of 95%, and the UK disease prevalence of 0.24% reported in May 2020. Subsequently, a case fatality rate of 20.5% was applied as a worst-case scenario. Results. The probability of SARS-CoV-2 infection with a false negative preoperative test was 0.07% (around 1 in 1,400). The risk of a patient with an undetected infection being admitted for surgery and subsequently dying from the coronavirus disease 2019 (COVID-19) is estimated at approximately 1 in 7,000. However, if an estimate of the current global infection fatality rate (1.04%) is applied, the risk of death would be around 1 in 140,000, at most. This calculation does not take into account the risk of nosocomial infection. Conversely, it does not factor in that patients will also be clinically assessed and asked to self-isolate prior to surgery. Conclusion. Our estimation suggests that the risk of patients being inadvertently admitted with an undetected SARS-CoV-2 infection for elective orthopaedic surgery is relatively low. Accordingly, the risk of death following elective orthopaedic surgery is low, even when applying the worst-case fatality rate. Cite this article: Bone Joint J 2020;102-B(9):1256–1260

Myxofibrosarcoma (MFS) is the second most common subtype of soft tissue sarcoma (STS) and is associated with a high rate of local recurrence after resection. These tumours frequently present with peri-lesional edema, termed “tumour tails” on staging MRI scans [1]. Tumour tails(TT) may contain satellite neoplastic cells or can represent benign reactive edema. There are no clear radiological features to distinguish malignant from reactive peri-lesional edema which limits accurate surgical planning, resulting in either high rates of inadvertently positive resection margins and local recurrences or overly-aggressive resections which negatively impact function and increase morbidity [2]. The objective of this pilot study was to prospectively study a cohort of MFS patients with TTs in an attempt to identify radiological features that predict which type of edema is malignant and requires resection together with the main tumour mass. Patients diagnosed with MFS on biopsy at an orthopaedic oncology referral centre between January 1-December 31 2018 who also had TTs on staging MRI scans were prospectively recruited for the study. Tumours were treated with wide surgical excision, including the TTs, and (neo)adjuvant radiotherapy as per institutional protocol. Staging MRI scans were reviewed in a blinded fashion by two musculoskeletal radiologists to distinguish malignant from reactive TTs. The main tumour mass underwent standard histological evaluation while the regions encompassing the TTs were photographed and sectioned into grids. Each tissue section was examined histologically for the presence of satellite neoplastic cells based on morphological criteria. Radiological and histological findings were compared. Six patients met the inclusion criteria and underwent analysis. All tumours were located in the extremities and were deep to fascia. Mean age at presentation was 67 years (range 51 – 85), with a male:female ratio of 4:2. All patients received radiotherapy (50 Gy), either pre- (n=4) or post-operatively (n=2) based on multidisciplinary tumor board discussion or enrolment in a prospective clinical trial. Radiologically, TTs were labelled as malignant in four patients (66.7%) and as benign TTs in two others. The tails were recognised to be malignant due to the differing signal characteristics to reactive edema on mixed MRI sequences. The radiological evaluation correlated exactly with histological analysis, as satellite neoplastic cells were identified microscopically in the same four cases in which the TTs were designated to be malignant by MRI (specificity&sensitivity=100%). Surgical resection margins were microscopically positive in 50% of cases in the TTs themselves, and 75% of cases in which TTs were designated as malignant on staging MRI. “The malignant nature of peri-lesional edema in MFS, also known as the TT, was accurately predicted in this small pilot study based on specific radiological features which correlated exactly with histologic identification of isolated tumor cells. These findings validate development of a larger prospective study to recruit additional patients with tumor tails beyond just MFS, in order to more robustly study the correlation between the MRI appearance and histological distribution of satellite sarcoma cells in peri-lesional edema in STS. We are already recruiting to this expanded radiological-histological investigation including evaluation of additional novel MRI sequences

Background. Use of a robotic tool to perform surgery introduces a risk of unexpected soft tissue damage due to the uncommon tactile feedback for the surgeon. Early experience with robotics in total hip and knee replacement surgery reported having to abort the procedure in 18–34 percent of cases due to inability to complete preoperative planning, hardware and soft tissue issues, registration issues, as well as concerns over actual and potential soft tissue damage. These can result in significant morbidity to the patient, negating all the desired advantages of precision and reproducibility with robotic assisted surgery. The risk of soft tissue damage can be mitigated by haptic software prohibiting the cutting tip from striking vital soft tissues and by the surgeon making sure there is a clear workspace path for the cutting tool. This robotic total knee system with a semi-active haptic guided technique was approved by the FDA on 8/5/2015 and commercialized in August of 2016. Two year clinical results have not been reported to date. Objective. To review an initial and consecutive series of robotic total knee arthroplasties for safety in regard to avoidance of known or delayed soft tissue injuries and the necessity to abort the using the robot to complete the procedure. Report the clinical outcomes with robotic total knee replacement at or beyond two years to demonstrate no delayed effect on expected outcome. Methods. The initial consecutive series of 65 Triathlon. TM. total knee replacements using a semi-active haptic guided system that were performed after commercialization that would be eligible for two year follow-up were reviewed. Pre-operative planning utilizing CT determined the implant placement and boundaries and thus the limit of excursion from any part of the end effector saw tip. Self-retaining retractors were also utilized. Operative reports, 2, 6, and 12 week, and yearly follow-up visit reports were reviewed for any evidence of inadvertent injury to the medial collateral ligament, patellar tendon, or a neurovascular structure from the cutting tool. Operative notes were also reviewed to determine if the robotic procedure was partially or completely aborted due to any issue. Knee Society Knee Scores (KS-KS) and Functional Scores (KS-FS) were recorded from pre-operative and yearly. Any complications were recorded. Results. 40 cases had two year follow-up. The average follow-up for this series was 1.51 years. No cases were unable to be completed robotically. No case had evidence for acute or delayed injury to the medial collateral ligament, patellar tendon, or neurovascular structure. The only complication was a revision total knee for tibial component loosening after a fall induced periprosthetic tibial fracture. Average pre-operative KS-KS and KS-FS improved from 46.9 and 52.1 to 99.2 and 88.6 at one year follow-up, 100.5 and 86.9 at two year follow-up. Conclusions. A semi-active haptic guided robotic system is a safe and reliable method to perform total knee replacement surgery. This series of initial robotic arm assisted surgery had no intraoperative or delayed soft tissue injuries. Preliminary short-term outcomes at up to two years show excellent outcomes

Introduction. Patient Specific Guides (PSGs) are used to increase the accuracy of arthroplasty. PSGs achieve this by incorporating geometry that fits in one unique position and orientation on a patient's bone. Sufficient docking rigidity ensures PSGs do not shift before being fixed by pins. Despite the importance of PSG docking rigidity, minimal research has been conducted on this issue. This study aims to determine whether commercially available PSGs, in their equilibrium position, provide sufficient stability for reliable surgical use. Materials and Methods. A commercially available PSG (Glenoid PSG, BLUEPRINT™, Wright Medical) was analyzed and tested in this study; the mechanical performance of this guide was assessed using a custom testing apparatus mounted to a universal testing machine (UTM) (MTI-10k, Materials Testing Inc), assembled with a high-precision load cell (MiniDyn Type 9256C, Kistler). The apparatus accepts an additively manufactured glenoid surrogate and was designed to transform vertical crosshead forces from the UTM into PSG-applied forces transverse to the glenoid plane along anterior-posterior and superior-inferior axes and PSG-applied torques about lateral, anterior, and superior axes. Three trials were recorded for each force and torque application. Prior to each test, the glenoid surrogate and PSG were articulated together with a constant 27N compressive force — equivalent to the normal force exerted by a surgeon using the guide — applied using springs. Forces were recorded when the guide was displaced 2mm by transverse loads or 5° by torque application; if the guide visibly dislodged from the glenoid surrogate before either criterion was met, force was recorded at the time of dislodgement. If no PSG movement occurred, testing ceased at 75N or 1.19N⋅m, depending on the test type. Results. The lowest and highest torques to displace the PSG by 5° were around the lateral (−0.08±0.02 N⋅m) and superior axes (0.87±0.23 N⋅m), respectively. The lowest and highest forces to displace the PSG by 2mm were along the inferior (31.77± 6.30N) and posterior axes (64.80±0.79N), respectively. Although it yielded at a higher torque than about the lateral axis, CCW rotation about the posterior axis produced the earliest PSG dislodgement at 3.76° while the PSG dislodged after only 1.05mm in the anterior direction. Discussion. The above results demonstrate that the tested PSG design produces similar docking rigidity for all tested rotations except rotations about the lateral axis, which provided 4 times less stability than the next lowest result. This indicates that the PSG may not provide sufficient resistance in this direction to prevent inadvertent mal-rotation. The relatively low rigidity in anterior and superior translation indicate that this PSG design may be prone to mal-positioning errors in these directions. With these data in mind, PSG docking rigidity is not equal in all loading directions which could play a role in the clinical accuracy. Furthermore, this indicates that a systematic, objective method for PSG design optimization may be warranted. For any figures or tables, please contact authors directly

Two stage exchange has been the gold standard in North America for the treatment of infected knee replacements. The choice of static vs. articulated spacers has been debated for a number of years. At our institution our choice of spacer for 2 stage exchanges is an articulated spacer. This allows motion between stages which facilitates recovery, and makes the second stage technically easier. In a study from our institution we followed 115 infected TKAs treated with the PROSTALAC articulated spacer for 5–9 years. Success for eradication of infection was 88%. With a repeat 2 stage, overall infection control was 98%. In addition, we compared functional outcomes to a group of aseptic knee revisions and found no difference in functional outcomes with standard quality of life outcome scores. While the articulated spacer was our treatment of choice in 2 stage exchange around 2012, the company that manufactured the PROSTALAC knee components ceased to manufacture them. At that time, based on the work of 2 previous studies (Hofmann, Lee), we continued to use articulated spacers. However, this was now the so-called Hofmann technique with a new standard femoral component with an all polyethylene tibia. The only difference from a standard knee revision was no stems and the utilization of high dose antibiotics. We also followed the principles from Europe of one stage exchange, such as wide debridement and soaking in dilute betadine for 15 minutes. More recently as of Sept 2015 we have used an all polyethylene tibia with a keel. The hope being that this will give a more stable tibia than previous and perhaps make a second stage unnecessary. Our first case was September 2015. The intention was not to do a second stage if the infection was eradicated and the patient had good pain relief and function. To date we have implanted 28 of these and in 80% of cases we have not had to do a second stage revision. Further study will reveal where this inadvertent one stage fits in our practi

The extended proximal femoral osteotomy has been used primarily in conjunction with cementless fixation, but has been described for use with cemented stems as well. The extended proximal femoral osteotomy is indicated for the removal of well-fixed cemented and cementless implants, as well as removal of cement in patients with a loose femoral component in a well-fixed cement mantle. Although the osteotomy is not required for many femoral revisions, it is an absolute indication in patients with femoral component loosening and subsequent varus remodeling of the proximal femur. The osteotomy diminishes the risk of an inadvertent fracture of the often compromised greater trochanter especially upon removal of a failed femoral component from its subsided or migrated position. The osteotomy enhances the exposure of the acetabulum which may be difficult in the revision setting due to multiple surgeries, severe migration of the acetabular component or the heterotopic ossification. The extended proximal femoral osteotomy can also be used in the primary setting when a proximal femoral deformity interferes with straight reaming of the femoral canal, such as in patients with various dysplasias, previous corrective osteotomies or malunions

Background. Use of a robotic tool to perform surgery introduces a risk of unexpected soft tissue damage due to the lack of tactile feedback for the surgeon. Early experience with robotics in total hip and knee replacement surgery reported having to abort the procedure in 18–34 percent of cases due to inability to complete preoperative planning, hardware and soft tissue issues, registration issues, as well as concerns over actual and potential soft tissue damage. These damages to the soft tissues resulted in significant morbidity to the patient, negating all the desired advantages of precision and reproducibility with robotic assisted surgery. The risk of soft tissue damage can be mitigated by haptic software prohibiting the cutting tip from striking vital soft tissues and by the surgeon making sure there is a clear workspace path for the cutting tool. This robotic total knee system with a semi-active haptic guided technique was approved by the FDA on 8/5/2015 and commercialized in August of 2016. One year clinical results have not been reported to date. Objective. To review an initial and consecutive series of robotic total knee arthroplasties for safety in regard to avoidance of known or delayed soft tissue injuries and the necessity to abort the robotic assisted procedure and resort to the use of conventional implantation. Report the clinical outcomes with robotic total knee replacement at or beyond one year to demonstrate satisfactory to excellent performance. Methods. The initial consecutive series of 100 robotic total knee replacements using a semi-active haptic guided system including 34 from the initial IDE series in 2014 and those performed after commercial approval beginning in 2016 were reviewed. Pre- operative planning utilizing CT determined the implant placement and boundaries and thus the limit of excursion from any part of the end effector saw tip. Self-retaining retractors were also utilized. Operative reports, 2, 6, and 12 week, and yearly follow-up visit reports were reviewed for any evidence of inadvertent injury to the medial collateral ligament, patellar tendon, or a neurovascular structure from the cutting tool. Operative notes were also reviewed to determine if the robotic procedure was partially or completely aborted due to any issue. Knee Society and Functional scores were recorded from pre-operative and yearly. Results. No cases were unable to be completed robotically. No case had evidence for acute or delayed injury to the medial collateral ligament, patellar tendon, or neurovascular structure. The average follow-up for this series was 1.54 years. Average pre- operative Knee Society and Functional Scores improved from 44.7 and 50 to 98.1 and 87.8 at one year follow-up, 93.8 and 83.1 at two year follow-up, 98.5 and 87.7 at three year follow-up, and 99 and 85 at four year follow-up. Conclusions. A semi-active haptic guided robotic system is a safe and reliable method to perform total knee replacement surgery. Preliminary short-term outcomes data shows excellent clinical and functional results

It is unusual to require the use of a total knee implant with more constraint than a posterior-stabilised post in primary knee arthroplasty. The most common indication is a knee with a severe deformity, usually fixed valgus with an incompetent medial collateral ligament, and an inability to correctly balance the knee in both flexion and extension. The pre-operative deformity is usually greater than 15–20 degrees fixed valgus and may be associated with a severe flexion contracture. This is usually seen in an elderly female patient with advanced osteoarthritis. Those pre-operative diagnoses more likely to require a constrained design include advanced rheumatoid arthritis, true neuropathic joint, and the “Charcot-like” joint due to bone loss or crystalline arthritis. Rarely, patients with periarticular knee Paget's disease of bone may require more constraint following correction of a severe deformity through the knee joint. Beware those patients with a staple or screw at the medial epicondyle or those with severe heterotopic ossification at the medial joint line, as this may signify a serious prior injury to the medial collateral ligament. Finally, there is a possibility of inadvertent division of the medial collateral ligament intra-operatively. Although this situation may be treated with suture repair and bracing, my choice is to switch to more constraint and early unbraced motion. There are over 20 designs of varus-valgus constrained components, with a variety of tibial post designs with specific rotary and angular biomechanics, and many have the option of adding modular stems. Our experience with constrained, non-linked designs has been favorable with both the use of nonmodular and modular stem extensions. Longer-term survival analysis has shown a 96% survival at 10 years with these constrained components. However, the older designs frequently required a lateral retinacular release for proper patella tracking, and there were patella complications (fracture and osteonecrosis) in 16%. With a more modern design, over the past 12 years, the need for a lateral retinacular release and patella complications have been notably decreased. Varus-valgus constrained components have a small but important role in primary total knee arthroplasty for patients with severe deformity or an incompetent medial collateral ligament

The extended proximal femoral osteotomy has been used primarily in conjunction with cementless fixation, but has been described for use with cemented stems as well. The extended proximal femoral osteotomy is indicated for the removal of well-fixed cemented and cementless implants, as well as removal of cement in patients with a loose femoral component in a well-fixed cement mantle. Although the osteotomy is not required for many femoral revisions, it is an absolute indication in patients with femoral component loosening and subsequent varus remodeling of the proximal femur. The osteotomy diminishes the risk of an inadvertent fracture of the often compromised greater trochanter especially upon removal of a failed femoral component from its subsided or migrated position. The osteotomy enhances the exposure of the acetabulum which may be difficult in the revision setting due to multiple surgeries, severe migration of the acetabular component or heterotopic ossification. The extended proximal femoral osteotomy can also be used in the primary setting when a proximal femoral deformity interferes with straight reaming of the femoral canal, such as in patients with various dysplasias, previous corrective osteotomies or malunions

Two stage exchange has been the gold standard in North America for the treatment of infected knee replacements. The choice of static versus articulated spacers has been debated for a number of years. At our institution our choice of spacer for two-stage exchanges is an articulated spacer. This allows motion between stages which facilitates recovery, and makes the second stage technically easier. In a study from our institution we followed 115 infected TKAs treated with the PROSTALAC articulated spacer for 5–9 years. Success for eradication of infection was 88%. With a repeat two stage overall infection control was 98%. In addition we compared functional outcomes to a group of aseptic knee revisions and found no difference in functional outcomes with standard quality of life outcome scores. While the articulated spacer was our treatment of choice in two-stage exchange around 2012 the company that manufactured the PROSTALAC knee components ceased to manufacture them. At that time based on the work of 2 previous studies (Hofmann, Lee), our institution continued to use articulated spacers. However, this was now the so-called Hofmann technique with a new standard femoral component with an all-polyethylene tibia. The only difference from a standard knee revision was no stems and the utilisation of high dose antibiotics. We also followed the principles from Europe of one-stage exchange, such as wide debridement and soaking in dilute betadine for 15 minutes. More recently, as of Sept 2015, we have used an all-polyethylene tibia with a keel. The hope being that this will give a more stable tibia than previous and perhaps make a second stage unnecessary. Our first case was September 2015. The intention was not to do a second stage if the infection was eradicated and the patient had good pain relief and function. To date we have implanted 12 of these and in all cases we have not had to do a second stage revision. Further study will reveal where this inadvertent one stage fits in our practice

Two stage exchange has been the gold standard in north America for the treatment of infected knee replacements. The choice of static versus articulated spacers has been debated for a number of years. At our institution our choice of spacer for 2 stage exchanges is an articulated spacer. This allows motion between stages which facilitates recovery, and makes the second stage technically easier. In a study from our institution we followed 115 infected TKAs treated with the PROSTALAC articulated spacer for 5–9 years. Success for eradication of infection was 88%. With a repeat two stage overall infection control was 98%. In addition we compared functional outcomes to a group of aseptic knee revisions and found no difference in functional outcomes with standard quality of life outcome scores. While the articulated spacers was our treatment of choice in 2 stage exchange around 2012 the company that manufactured the PROSTALAC knee components ceased to manufacture them. At that time based on the work of 2 previous studies (Hofmann, Lee), at our institution we continued to use articulated spacers. However, this was now the so called Hofmann technique with a new standard femoral component with an all polyethylene tibia. The only difference from a standard knee revision was no stems and the utilization of high dose antibiotics. We also followed the principles from Europe of one stage exchange, such as wide debridement and soaking in dilute betadine for 15 minutes. More recently as of Sept 2015 we have used an all-polyethylene tibia with a keel. The hope being that this will give a more stable tibia than previous and perhaps make a second stage unnecessary. Our first case was September 2015. The intention was not to do a second stage if the infection was eradicated and the patient had good pain relief and function. To date we have implanted 12 of these and in all cases we have not had to do a second stage revision. Further study will reveal where this inadvertent one stage fits in our practice

My goal for every patient undergoing THA is to achieve a perfect result. At the very least this includes no pain at any time, normal range of motion, normal functionality and a minimal chance of a second operation. Both the Posterolateral Approach (PLA) and the Direct Anterior Approach (DAA) have the capability of achieving these important goals. However, when you dive deeper into the goal of a “perfect” THA, some differences between the approaches become apparent. These include less muscle damage, faster recovery, and no restrictions at any time with the DAA as opposed to the PLA. Also there is some evidence of better wound healing (Poehling) and less chance of thromboembolic disease with the DAA (Stryker). The PLA violates all posterior structures of the hip joint, and specifically also goes through the gluteus maximus muscle. Done properly, the DAA spares all the gluteal muscles, and all of the posterior muscles about the hip. Bergin, who demonstrated lower levels of creatine kinase using the DAA vs PLA, has provided evidence of lower muscle damage. Faster recovery patterns have been well documented after DAA (Christen, Taunton). Part of this may be related to not needing hip precautions after DAA, while PLA patients are restricted in certain activities and positions in the postoperative period, because of the violation of the posterior capsule. Not having any restrictions enhances patient confidence, and patients tend to do more activities sooner with less reluctance and a subsequent faster recovery. It is my belief that DAA problems (outside the learning curve) are related to the dependence upon special tables and fluoroscopy, as opposed to proper exposure, to perform a DAA. If you don't test hip stability in the OR, you will miss subtle impingement that can lead to postoperative dislocation. If you depend upon fluoroscopy to guide acetabular reaming (without proper exposure), you run the risk of over-reaming or asymmetric reaming with dire consequences. If you don't measure leg length directly, but rely on fluoroscopic measurements, you run the risk of inadvertent leg lengthening

The use of constrained condylar components (CCK) in primary total knee arthroplasty is infrequent and unusual. The usual indications are a severe fixed valgus deformity with a stretched or incompetent medial collateral ligament (MCL). This may occur in an elderly female patient with valgus osteoarthritis, advanced rheumatoid arthritis, or other less common disorders: polio, Parkinson's disease, and Paget's disease involving the knee. It may also be seen in younger patients with post-traumatic arthritis. Beware of the patient with a prior history of a knee injury in which staples were placed at the medial epicondyle of the femur or proximal tibia, indicating likely MCL injury, or a knee with extensive medial joint heterotopic ossification. An unusual indication for a primary CCK component is inadvertent injury or sectioning of the MCL during the procedure. This can occur with over-zealous medial ligament release or division with the saw during the posterior femoral condylar or proximal tibial resection. This has been reported to occur in <1% to 2.7% of knees. Treatment alternatives are to attempt repair and brace the knee or perform “internal bracing” with a CCK component. The author strongly favors the use of CCK components in this situation. We permit early full-weightbearing and range of motion, without restrictions. Careful intraoperative attention to component rotation is crucial to avoid patellar complications. The results of CCK components by the author and others have demonstrated a high rate of survival at 10 years, even in younger patients

Aims

Early large treatment effects can arise in small studies, which lessen as more data accumulate. This study aimed to retrospectively examine whether early treatment effects occurred for two multicentre orthopaedic randomized controlled trials (RCTs) and explore biases related to this.

Two-stage treatment of chronically infected TKA is the most common form of management in North America and most parts of the world. One-stage management has pros and cons which will not be discussed in this lecture. There is great variation of techniques and timing and little data to definitively support one technique or timing approach vs. another. Most methods are based on empirical success and logic. At the time of surgery, the first step is removal of infected implants. All metallic implants and cement should be removed. The most common places to leave cement behind inadvertently include patellar lug holes, femoral lug holes, and the anterior proximal tibia behind the tibial tubercle. Formal synovectomy should be performed. The next step is typically antibiotic-impregnated spacer placement. There are pros and cons of dynamic and static spacers with no clear evidence of superiority of one vs. another. Dynamic spacers work satisfactorily with mild to moderate bone loss, but more severe bone loss is usually better treated with static spacers and a cast. Most antibiotic spacers are made of methyl methacrylate cement with addition of high-dose antibiotics. In most cases, doses of 4–8 gm of antibiotics per pack of cement are preferred. The type of dosing depends on the specific antibiotic and the type of cement used. The most common antibiotics used are vancomycin and gentamycin. When the femoral canals have been instrumented, antibiotic-impregnated cement wands are usually placed in the medullary canal, as the medullary canals have been shown to have high risk of residual bacteria being present. The resection interval may vary and there is no clear evidence of a “best” resection interval. Practically speaking, most surgeons use a resection period of 8–16 weeks depending on the type of spacer utilised. During the resection interval, serum markers (ESR and CRP) are followed periodically. One anticipates a decline or normalization of these parameters prior to second stage reimplantation procedure. There has not been a demonstrated advantage to reaspiration of the knee before reimplantation in most circumstances. At the time of reimplantation, the spacers are removed and the knee is redebrided. The key at the time of reimplantation is to obtain good implant fixation but to also balance this with the potential for manageable extraction of the implants at some later date. Good implant fixation is important because failure rates due to mechanical failure are approximately equal to those of failure due to reinfection by 10 years. It is important to remember that reinfection risk is at least 10% by ten years, and therefore extractability of implants is also important. Post-operative management typically includes IV antibiotics, followed by oral antibiotics until final intra-operative cultures are available. The results of two-stage reimplantation are reported in many series. Most show approximately 85–95% rate of successful eradication of infection in the first five years. Reinfections, often with different organisms, may occur even late after reimplantation. By ten years after surgery survival free of mechanical failure and infection in most series drops to 80% or less due to recurrent infections and mechanical failures

The well-fixed cemented femoral stem and surrounding cement can be challenging to remove. Success requires evaluation of the quality of the cement mantle (interface lucency), position of the stem, extent of cement below the tip of the stem and skill with the specialised instruments and techniques needed to remove the stem and cement without perforating the femur. Smooth surfaced stems can usually be easily removed from the surrounding cement mantle with a variety of stem extractors that attach to the trunnion or an extraction hole on the implant. Roughened stems can be freed from the surrounding cement mantle with osteotomes or a narrow high speed burr and then extracted with the above instruments. Following this, the well-fixed cement mantle needs to be removed. Adequate exposure and visualization of the cement column is essential to remove the well-fixed cement without damage to the bone in the femur. This is important since fixation of a revision femoral component typically requires at least 4 cm of contact with supportive cortical bone, which can be difficult to obtain if the femur is perforated or if the isthmus damaged. Proximally, cement in the metaphyseal region can be thinned with a high speed burr, then split radially and removed piecemeal. It is essential to remember that both osteotomes and high speed burrs will cut thru bone easier than cement and use of these instruments poses a substantial risk of unintended bone removal and perforation of the femur if done improperly. These instruments should, as a result, be used under direct vision. Removal of more distal cement in the femur typically requires use of an extended femoral osteotomy (ETO) to allow for adequate access to the well-fixed cement in the bowed femoral canal. An ETO also facilitates more efficient removal of cement in the proximal femur. The ETO should be carefully planned so that it is distal enough to allow for access to the end of the cement column and still allow for stable fixation of a new implant. Too short of an ETO increases the risk of femoral perforation since the straight cement removal instruments cannot negotiate the bowed femoral canal to access the end of the cement column without risk of perforation. An ETO that is too distal makes cement removal easier, but may not allow for sufficient fixation of a new revision femoral stem. Cement below the level of the ETO cannot be directly visualised and specialised instruments are necessary to safely remove this distal cement. Radiofrequency cement removal devices use high frequency (ultrasonic) radio waves to melt the cement within the canal. Although cement removal with these devices is time consuming and tedious, they do substantially reduce the chances of femoral perforation. These devices can, however, generate considerable heat locally and can result in thermal injury to the bone and surrounding tissues. Once the distal end of the cement mantle is penetrated, backbiting or hooked curettes can be use to remove any remaining cement from within the canal. It is important that all cement be removed from the femur since reamers used for preparation of the distal canal will be deflected by any retained cement, which could result in eccentric reaming and inadvertent perforation of the femur and make fixation of a new implant very challenging. An intra-operative x-ray can be very helpful to insure that all cement has been removed before reaming is initiated. One should always plan for a possible femoral perforation and have cortical strut grafts and a stem available that will safely bypass the end of the cement column and the previous cement restrictor

Aim:. Historically, anterior decompression followed by posterior fusion has been the surgical management of choice in spinal tuberculosis. Due to theatre time being at a premium, we have evolved to performing anterior only debridement, allograft strut reconstruction and instrumentation for tuberculosis in the adult thoracic spine. The aim of this study is to review the safety and the efficacy of this treatment. Methods:. Twenty-eight adult thoracic tuberculosis patients were identified where anterior only surgery had been performed. These were all in the mid-thoracic spine as circumferential surgery is still favoured in thoracolumbar disease. The surgery was performed by a single surgeon at a tertiary hospital. Following transthoracic aggressive debridement, allograft humeral shafts were cut to size and inserted under compression and the spines instrumented with the use of screw-rod constructs into the body above and below. A retrospective review of clinical notes and radiological studies was performed. Results:. Twenty-seven of the patients presented with altered neurology; 2 had only sensory changes while 25 presented with paraparesis; 22 of these patients were unable to walk. The average surgical time was 2 hours 20 minutes with a median blood loss of 726 ml. The majority of patients had 2 vertebral bodies involved and required an average of a 4 body fusion. Surgical complications included inadvertent opening of the diaphragm in 1 patient and 1 patient deteriorated neurologically post operatively. 21 of 28 patients recovered to independent mobility at their latest follow-up appointment. 1 patient showed no recovery, 3 had some motor recovery that was not useful, 1 had some sensory but no motor recovery. 16 of 28 patients have documented bony fusion with no evidence of instrumentation failure in any patients. Conclusion:. Anterior only debridement, allograft strut reconstruction and instrumented fusion for the treatment of thoracic spinal tuberculosis is a safe and effective alternative to circumferential surgery in the adult patient